A Combination of Zarnestra With Velcade for Patients With Relapsed Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00361088
Recruitment Status : Terminated (Initial Principal Investigator left Moffitt)
First Posted : August 7, 2006
Last Update Posted : November 25, 2013
Millennium Pharmaceuticals, Inc.
National Cancer Institute (NCI)
Information provided by:
H. Lee Moffitt Cancer Center and Research Institute

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : June 2007
  Actual Study Completion Date : June 2007